Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: Pathological and clinical implications

Marie Lise Jaffrain-Rea, Mariolina Angelini, Donatella Gargano, Maria A. Tichomirowa, Adrian F. Daly, Jean François Vanbellinghen, Emanuela D'Innocenzo, Anne Barlier, Felice Giangaspero, Vincenzo Esposito, Luca Ventura, Antonietta Arcella, Marily Theodoropoulou, Luciana A. Naves, Carmen Fajardo, Sabina Zacharieva, Vincent Rohmer, Thierry Brue, Alberto Gulino, Giampaolo CantoreEdoardo Alesse, Albert Beckers

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIPmut). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (Pmut PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype.

Original languageEnglish
Pages (from-to)1029-1043
Number of pages15
JournalEndocrine-Related Cancer
Volume16
Issue number3
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Aryl Hydrocarbon Receptors
Pituitary Neoplasms
Proteins
Immunohistochemistry
Mutation
Germ-Line Mutation
aryl hydrocarbon receptor-interacting protein
Real-Time Polymerase Chain Reaction
Down-Regulation
Phenotype
Genes

ASJC Scopus subject areas

  • Endocrinology
  • Oncology
  • Cancer Research
  • Endocrinology, Diabetes and Metabolism

Cite this

Jaffrain-Rea, M. L., Angelini, M., Gargano, D., Tichomirowa, M. A., Daly, A. F., Vanbellinghen, J. F., ... Beckers, A. (2009). Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: Pathological and clinical implications. Endocrine-Related Cancer, 16(3), 1029-1043. https://doi.org/10.1677/ERC-09-0094

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas : Pathological and clinical implications. / Jaffrain-Rea, Marie Lise; Angelini, Mariolina; Gargano, Donatella; Tichomirowa, Maria A.; Daly, Adrian F.; Vanbellinghen, Jean François; D'Innocenzo, Emanuela; Barlier, Anne; Giangaspero, Felice; Esposito, Vincenzo; Ventura, Luca; Arcella, Antonietta; Theodoropoulou, Marily; Naves, Luciana A.; Fajardo, Carmen; Zacharieva, Sabina; Rohmer, Vincent; Brue, Thierry; Gulino, Alberto; Cantore, Giampaolo; Alesse, Edoardo; Beckers, Albert.

In: Endocrine-Related Cancer, Vol. 16, No. 3, 09.2009, p. 1029-1043.

Research output: Contribution to journalArticle

Jaffrain-Rea, ML, Angelini, M, Gargano, D, Tichomirowa, MA, Daly, AF, Vanbellinghen, JF, D'Innocenzo, E, Barlier, A, Giangaspero, F, Esposito, V, Ventura, L, Arcella, A, Theodoropoulou, M, Naves, LA, Fajardo, C, Zacharieva, S, Rohmer, V, Brue, T, Gulino, A, Cantore, G, Alesse, E & Beckers, A 2009, 'Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: Pathological and clinical implications', Endocrine-Related Cancer, vol. 16, no. 3, pp. 1029-1043. https://doi.org/10.1677/ERC-09-0094
Jaffrain-Rea, Marie Lise ; Angelini, Mariolina ; Gargano, Donatella ; Tichomirowa, Maria A. ; Daly, Adrian F. ; Vanbellinghen, Jean François ; D'Innocenzo, Emanuela ; Barlier, Anne ; Giangaspero, Felice ; Esposito, Vincenzo ; Ventura, Luca ; Arcella, Antonietta ; Theodoropoulou, Marily ; Naves, Luciana A. ; Fajardo, Carmen ; Zacharieva, Sabina ; Rohmer, Vincent ; Brue, Thierry ; Gulino, Alberto ; Cantore, Giampaolo ; Alesse, Edoardo ; Beckers, Albert. / Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas : Pathological and clinical implications. In: Endocrine-Related Cancer. 2009 ; Vol. 16, No. 3. pp. 1029-1043.
@article{337959581a534f0b990801ae3858bd9e,
title = "Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: Pathological and clinical implications",
abstract = "Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIPmut). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (Pmut PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype.",
author = "Jaffrain-Rea, {Marie Lise} and Mariolina Angelini and Donatella Gargano and Tichomirowa, {Maria A.} and Daly, {Adrian F.} and Vanbellinghen, {Jean Fran{\cc}ois} and Emanuela D'Innocenzo and Anne Barlier and Felice Giangaspero and Vincenzo Esposito and Luca Ventura and Antonietta Arcella and Marily Theodoropoulou and Naves, {Luciana A.} and Carmen Fajardo and Sabina Zacharieva and Vincent Rohmer and Thierry Brue and Alberto Gulino and Giampaolo Cantore and Edoardo Alesse and Albert Beckers",
year = "2009",
month = "9",
doi = "10.1677/ERC-09-0094",
language = "English",
volume = "16",
pages = "1029--1043",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "BioScientifica Ltd.",
number = "3",

}

TY - JOUR

T1 - Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas

T2 - Pathological and clinical implications

AU - Jaffrain-Rea, Marie Lise

AU - Angelini, Mariolina

AU - Gargano, Donatella

AU - Tichomirowa, Maria A.

AU - Daly, Adrian F.

AU - Vanbellinghen, Jean François

AU - D'Innocenzo, Emanuela

AU - Barlier, Anne

AU - Giangaspero, Felice

AU - Esposito, Vincenzo

AU - Ventura, Luca

AU - Arcella, Antonietta

AU - Theodoropoulou, Marily

AU - Naves, Luciana A.

AU - Fajardo, Carmen

AU - Zacharieva, Sabina

AU - Rohmer, Vincent

AU - Brue, Thierry

AU - Gulino, Alberto

AU - Cantore, Giampaolo

AU - Alesse, Edoardo

AU - Beckers, Albert

PY - 2009/9

Y1 - 2009/9

N2 - Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIPmut). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (Pmut PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype.

AB - Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIPmut). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (Pmut PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype.

UR - http://www.scopus.com/inward/record.url?scp=70449950609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449950609&partnerID=8YFLogxK

U2 - 10.1677/ERC-09-0094

DO - 10.1677/ERC-09-0094

M3 - Article

C2 - 19556287

AN - SCOPUS:70449950609

VL - 16

SP - 1029

EP - 1043

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 3

ER -